| Literature DB >> 28035324 |
Keegan Zuk1, Derek Jensen1, Jessie Gills1, Hadley Wyre1, Jeffrey M Holzbeierlein1, Ernesto Lopez-Corona1, Eugene K Lee1.
Abstract
Background: The "July effect" is the potential effect that new and recently promoted residents have on patient care during the first months of the academic year. Literature suggests that the July effect may worsen patient outcomes and lead to systemic inefficiencies. Objective: We evaluate the July effect on mortality, morbidity, and efficiency outcomes in patients undergoing radical cystectomy.Entities:
Keywords: July effect; Radical cystectomy; efficiency markers
Year: 2016 PMID: 28035324 PMCID: PMC5181673 DOI: 10.3233/BLC-160059
Source DB: PubMed Journal: Bladder Cancer
Patient characteristics
| Total Patients | July/Sep/Nov | Rest of Year | ||
| Total number of pts. | 251 | 60 | 191 | |
| Age (years) | ||||
| Median | 70 | 68 | 70 | 0.71 |
| 25–75 percentile | 62–76 | 62–77 | 62–76 | |
| BMI | ||||
| Median | 29 | 29 | 28 | 0.76 |
| 25–75 percentile | 26–32 | 26–32 | 26–32 | |
| Gender | ||||
| Male (%) | 189 (75) | 47 (78) | 142 (74) | 0.53 |
| Female (%) | 62 (25) | 13 (22) | 49 (26) | |
| Surgery type | ||||
| Open (%) | 201 (80) | 48 (80) | 153 (80) | 0.99 |
| Robotic (%) | 50 (20) | 12 (20) | 38 (20) | |
| Diversion | ||||
| Ileal Conduit (%) | 152 (61) | 31 (53) | 121 (64) | 0.17 |
| Neobladder (%) | 95 (38) | 27 (47) | 68 (36) | |
| Missing (%) | 4 (2) | |||
| Neoadjuvant Chemotherapy | ||||
| No (%) | 173 (69) | 42 (70) | 131 (69) | 0.84 |
| Yes (%) | 78 (31) | 18 (30) | 60 (31) | |
| pStage | ||||
| T0,Ta,Cis | 40 (16) | 12 (20) | 28 (15) | 0.6 |
| T1 | 50 (20) | 8 (13) | 42 (22) | |
| T2 | 60 (24) | 15 (25) | 45 (24) | |
| T3 | 70 (28) | 18 (30) | 52 (27) | |
| T4 | 31 (12) | 7 (12) | 24 (13) |
Fig.1Kaplan Meier Curve of Overall Survival.
Univariate analysis according to groups and outcomes of interest
| Variables | Any | Major | OR time | EBL | LOS |
| (Total pts) | complication | complication | (Median and | (Median and | (Median and |
| (%) | (%) | 25-75th percentile | 25–75th | 25–75th | |
| Minutes) | percentile mL) | percentile Days) | |||
| Gender | |||||
| Female (69) | 29 (47) | 11 (18) | 360 (303–434) | 750 (500–1100) | 7 (6–9) |
| Male (189) | 103 (55) | 46 (24) | 324 (282–393) | 580 (350–800) | 7 (6–9) |
| Age | |||||
| ≤69 (120) | 67 (44) | 22 (18) | 348 (302–415) | 600 (375–900) | 7 (6–9) |
| >69 (131) | 65 (50) | 35 (27) | 315 (272–382) | 550 (300–800) | 7 (6–9) |
| BMI | |||||
| ≤29 (145) | 65 (45) | 30 (21) | 327 (282–414) | 600 (330–855) | 7 (6–9) |
| >29 (106) | 67 (63) | 27 (25) | 332 (289–399) | 600 (350–800) | 8 (6–11) |
| Surgery type | |||||
| Open (201) | 106 (52) | 41 (20) | 316 (272–367) | 600 (400–900) | 7 (6–9) |
| Robotic (50) | 26 (52) | 16 (32) | 414 (369–470) | 400 (250–600) | 7 (6–9) |
| Diversion | |||||
| Ileal Conduit (152) | 78 (51) | 36 (24) | 316 (272–372) | 600 (300–900) | 8 (6–9) |
| Neobladder (95) | 52 (55) | 20 (21) | 353 (300–434) | 600 (350–800) | 7 (6–9) |
| Neoadjuvant Chemotherapy | |||||
| No (173) | 93 (54) | 42 (24) | 324 (282–398) | 600 (350–800) | 7 (6–9) |
| Yes (78) | 39 (50) | 15 (19) | 345 (285–414) | 600 (350–900) | 7 (6–9) |
| Month of Surgery | |||||
| July/Sep/Nov (60) | 34 (57) | 17 (28) | 334 (284–410) | 600 (350–850) | 7 (6–9) |
| Rest of year (191) | 98 (51) | 40 (21) | 325 (287–382) | 525 (300–950) | 7 (6–9) |
Multivariable analysis by logistic regression for Operating Room time (OR time). OR time was dichotomized by the median (331 minutes) and odds ratios are demonstrated for greater versus lesser than median value
| OR Time (minutes) | OR (95% CI) |
| Female vs Male | 2.55 (1.28–5.08) |
| BMI | 1.06 (1.04–1.11) |
| Type of Surgery Open vs Robotic | 0.059 (0.02–0.15) |
| July/Sep/Nov vs rest of year | 2.06 (0.99–4.27) |
| Age | 0.96 (0.96–1) |
Other variables included in the analysis were type of diversion, use of neoadjuvant chemotherapy, and pStage. Variables that were NS were not included in the table.
Multivariable analysis by logistic regression for length of hospital stay (LOS). LOS was dichotomized by the median (7 days) and odds ratios are demonstrated for greater versus lesser than median value
| LOS (days) | OR (95% CI) |
| BMI | 1.05 (1.001–1.11) |
Variables also included in the analysis were gender, age, type of surgery, type of diversion, use of neoadjuvant chemotherapy, pStage, surgery done on July/Sep/Nov. Variables that were NS were not included in the table.
Multivariable analysis by logistic regression for estimated blood loss (EBL). EBL was dichotomized by the median (600 mL) and odds ratios are demonstrated for greater versus lesser than median value
| EBL (mL) | OR (95% CI) |
| Female vs Male | 1.94 (1.046–3.61) |
| Type of surgery Open vs Robotic) | 2.95 (1.38–6.18) |
Variables also included in the analysis were BMI, age, type of diversion, use of neoadjuvant chemotherapy, pStage, surgery done on July/Sep/Nov. Variables that were NS were not included in the table.